Page last updated: 2024-09-03

tetrahydrocurcumin and Diabetic Nephropathies

tetrahydrocurcumin has been researched along with Diabetic Nephropathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Khazaali, M; Khazaeli, M; Lau, WL; Nunes, ACF; Prudente, J; Singh, B; Vaziri, ND; Zhao, Y1

Other Studies

1 other study(ies) available for tetrahydrocurcumin and Diabetic Nephropathies

ArticleYear
Tetrahydrocurcumin Add-On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury.
    Pharmacology research & perspectives, 2023, Volume: 11, Issue:2

    Topics: Animals; Antioxidants; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrosis; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic

2023